alexa
Reach Us +44-176-4910199
Developments In The Treatment Of Crohn's Disease: From Steroids To Biological Therapy, Are We Really Improving The Prognosis? | 3523
ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Developments in the treatment of Crohn's disease: From steroids to biological therapy, are we really improving the prognosis?

2nd International Conference on Gastroenterology & Urology

Wilson Catapani

AcceptedAbstracts: J Gastrointest Dig Syst

DOI: 10.4172/2161-069X.S1.019

Abstract
Crohn's disease is a chronic illness that affects mostly young individuals, working at full capacity and in the reproductive phase of their lives, causing great impact on their quality of life. The disease affects labor productivity and psycho-social life of these patients either through symptoms like abdominal pain and chronic diarrhea, either through the presence of fistulas or the need for surgery. This talk will address the rates of success and complications of different treatments available over the years, from corticosteroids to biological therapy, with particular emphasis on the latter. We will analyze the changes in quality of life and clinical outcomes, the ability to avoid surgical indications and the complications of therapy itself.
Biography
C rohn's disease is a chronic illness that affects mostly young individuals, working at full capacity and in the reproductive phase of their lives, causing great impact on their quality of life. The disease affects labor productivity and psycho-social life of these patients either through symptoms like abdominal pain and chronic diarrhea, either through the presence of fistulas or the need for surgery. This talk will address the rates of success and complications of different treatments available over the years, from corticosteroids to biological therapy, with particular emphasis on the latter. We will analyze the changes in quality of life and clinical outcomes, the ability to avoid surgical indications and the complications of therapy itself.
Top